Tissue Regenix Group PLC UK Patient has world's first OrthoPure XM implant
March 05 2015 - 5:38AM
RNS Non-Regulatory
TIDMTRX
Tissue Regenix Group PLC
05 March 2015
UK Patient receives world's first OrthoPure(TM) XM (dCELL(R)
Meniscus) implant
5th March 2015
Tissue Regenix Ltd, the regenerative medical device company, is
pleased to announce that for the first time a patient has
successfully received a partial knee meniscal replacement using
Tissue Regenix's OrthoPure XM. This has been done at Mount Vernon
Hospital, Middlesex, as part of a clinical safety study by Tissue
Regenix which is being conducted to secure a CE mark to enable
launch of the product in the EU in 2016.
Mr David Houlihan-Burne performed the 'keyhole' surgical
procedure that allows the surgeon to replace damaged sections of
the knee meniscus with Tissue Regenix's decellularised tissue,
which preserves the biomechanical properties of the tissue in a
'like for like' repair.
Tissue Regenix's OrthoPure XM will be used to repair damage from
'tears' in the meniscus knee cartilage as a result of acute injury
or degeneration. Meniscal injuries affect around 1.5 million people
per year in Europe and USA, and OrthoPure XM potentially addresses
this substantial unmet clinical need.
Peter Hamer, Commercial Director of Orthopaedics at Tissue
Regenix commented:
"It is early days with this trial but I am pleased the Ortho
team have achieved this important milestone in our progress towards
launch. We are fortunate to be working with surgeons who recognise
the importance of innovative biologic solutions to this very common
type of injury."
Enquiries:
Tissue Regenix Group plc Tel: 01904 435 176
Antony Odell, Chief Executive Officer
Ian Jefferson, Chief Financial Officer
Tulchan Communications Tel: 020 7353 4200
Tom Buchanan / Victoria Huxster
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAEAEDSEDSSEFF
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Oct 2023 to Oct 2024